BIOX logo

Bioceres Crop Solutions Corp. Stock Price

NasdaqGS:BIOX Community·US$89.1m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 23 Fair Values set on narratives written by author

BIOX Share Price Performance

US$1.43
-6.02 (-80.81%)
82.1% undervalued intrinsic discount
US$8.00
Fair Value
US$1.43
-6.02 (-80.81%)
84.1% undervalued intrinsic discount
US$9.00
Fair Value
Price US$1.43
AnalystHighTarget US$9.00
AnalystConsensusTarget US$4.17
AnalystLowTarget US$6.00

BIOX Community Narratives

AnalystHighTarget·
Fair Value US$8 83.4% undervalued intrinsic discount

Sustainable Agriculture And Decarbonization Will Advance HB4 Crop Adoption

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AnalystConsensusTarget·
Fair Value US$4.17 68.1% undervalued intrinsic discount

Transition To Capital-Light Model And Global Expansion Will Shape Future Success

0users have liked this narrative
0users have commented on this narrative
13users have followed this narrative
AnalystLowTarget·
Fair Value US$2.5 46.8% undervalued intrinsic discount

Leverage And Argentina Risks Will Impede Performance But Spur Recovery

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Recent BIOX News & Updates

The Market Doesn't Like What It Sees From Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Revenues Yet As Shares Tumble 31%

Sep 15
The Market Doesn't Like What It Sees From Bioceres Crop Solutions Corp.'s (NASDAQ:BIOX) Revenues Yet As Shares Tumble 31%

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Not Doing Enough For Some Investors As Its Shares Slump 25%

Aug 01
Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Not Doing Enough For Some Investors As Its Shares Slump 25%

Bioceres Crop Solutions (NASDAQ:BIOX) Use Of Debt Could Be Considered Risky

Jul 22
Bioceres Crop Solutions (NASDAQ:BIOX) Use Of Debt Could Be Considered Risky

Bioceres Crop Solutions Corp. Key Details

US$333.3m

Revenue

US$203.1m

Cost of Revenue

US$130.2m

Gross Profit

US$182.0m

Other Expenses

-US$51.8m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
-0.83
Gross Margin
39.06%
Net Profit Margin
-15.54%
Debt/Equity Ratio
79.2%

Bioceres Crop Solutions Corp. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Undervalued with excellent balance sheet.

2 Risks
2 Rewards

About BIOX

Founded
2001
Employees
n/a
CEO
Federico Trucco
WebsiteView website
investors.biocerescrops.com/home/default.aspx

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops. The Crop Protection segment develops, produces, and markets Rizoderma, adjuvants, therapies, herbicides, insecticides, fungicides, and baits. The Crop Nutrition segment develops, produces, commercializes, and sells inoculants, bio-inductors, and biological and microgranulated fertilizers. It also offers HB4, a drought tolerant seed technology program. The company operates in Argentina, Brazil, North America, Europe, the Middle East, South America, the United States, and internationally. Bioceres Crop Solutions Corp. was founded in 2001 and is headquartered in Rosario, Argentina.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

Argentinian Market Performance

  • 7 Days: 5.3%
  • 3 Months: -6.7%
  • 1 Year: 3.6%
  • Year to Date: -31.7%
Over the last 7 days, the market has risen 5.3%, driven by gains of 13% in the Financials sector. As for the past 12 months, the market is up 3.6%. Earnings are forecast to grow by 34% annually. Market details ›